What is the address of Dr Leyder, pneumologue?

The registered office of Dr Leyder, pneumologue is located at Rue de Burhaimont 162, 6880 Bertrix.

Is Dr Leyder, pneumologue still active?

Yes. According to the CBE (30 October 2026) Dr Leyder, pneumologue is active, legal situation “Normale toestand”, started on 22 April 2022.

Is Dr Leyder, pneumologue registered on Peppol?

No, Dr Leyder, pneumologue is currently not registered on the Peppol network.

What is the enterprise number of Dr Leyder, pneumologue?

The enterprise number of Dr Leyder, pneumologue is BE0785338130.

When was Dr Leyder, pneumologue founded?

Dr Leyder, pneumologue was founded on 22 April 2022.

Who are the directors of Dr Leyder, pneumologue?

According to the 2025 annual accounts, the directors of Dr Leyder, pneumologue are: Emmanuel LEYDER.

Is Dr Leyder, pneumologue a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 April 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr Leyder, pneumologue make in 2025?

Dr Leyder, pneumologue posted a profit after taxes of € 142,337 in financial year 2025.

What is the revenue of Dr Leyder, pneumologue?

As a small company, Dr Leyder, pneumologue is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 236,126.

Dr Leyder, pneumologue (Private Limited) - Bertrix

Dossier Dr Leyder, pneumologue, printed on 30 October 2026 from databakkes.be/en/0785338130/dr-leyder-pneumologue. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr Leyder, pneumologue from Bertrix, company number BE0785338130, closed financial year 2025 with a result of € 142,337 after tax. For that financial year Dr Leyder, pneumologue recorded a gross margin of € 236,126 and equity of € 525,772. Compared with financial year 2024, the result moved from € 162,348 to € 142,337. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.

What it is worth Growing

€ 525,772

▲ 37% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 142,337

▼ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 226,828

▲ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 520,772.

Debts at end 2025

Bank debt ≈ 18 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 144,651

€ 8,240 is repaid this year. At this pace the long-term loan is gone in ≈ 18 years.

Owed to suppliers

€ 230

▼ 61% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,483

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 148,846 Gross margin 2022: € 148,846 First fiscal year in the series	€ 136,474 Gross margin 2023: € 136,474 ▼ 8% vs 2022 (€ 148,846) Unfavourable step	€ 213,052 Gross margin 2024: € 213,052 ▲ 56% vs 2023 (€ 136,474) Favourable step	€ 236,126 Gross margin 2025: € 236,126 ▲ 11% vs 2024 (€ 213,052) Favourable step	▲ 11%
Profit after taxes	€ 112,302 Profit after taxes 2022: € 112,302 First fiscal year in the series	€ 103,784 Profit after taxes 2023: € 103,784 ▼ 8% vs 2022 (€ 112,302) Unfavourable step	€ 162,348 Profit after taxes 2024: € 162,348 ▲ 56% vs 2023 (€ 103,784) Favourable step	€ 142,337 Profit after taxes 2025: € 142,337 ▼ 12% vs 2024 (€ 162,348) Unfavourable step	▼ 12%
Equity	€ 117,302 Equity 2022: € 117,302 First fiscal year in the series	€ 221,086 Equity 2023: € 221,086 ▲ 88% vs 2022 (€ 117,302) Favourable step	€ 383,435 Equity 2024: € 383,435 ▲ 73% vs 2023 (€ 221,086) Favourable step	€ 525,772 Equity 2025: € 525,772 ▲ 37% vs 2024 (€ 383,435) Favourable step	▲ 37%
Total debts	€ 47,273 Total debts 2022: € 47,273 First fiscal year in the series	€ 75,678 Total debts 2023: € 75,678 ▲ 60% vs 2022 (€ 47,273) Unfavourable step	€ 12,088 Total debts 2024: € 12,088 ▼ 84% vs 2023 (€ 75,678) Favourable step	€ 155,810 Total debts 2025: € 155,810 ▲ € 143,721 vs 2024 (€ 12,088) Unfavourable step	▲ € 143,721
Cash	€ 60,478 Cash 2022: € 60,478 First fiscal year in the series	€ 91,706 Cash 2023: € 91,706 ▲ 52% vs 2022 (€ 60,478) Favourable step	€ 208,588 Cash 2024: € 208,588 ▲ 127% vs 2023 (€ 91,706) Favourable step	€ 226,828 Cash 2025: € 226,828 ▲ 9% vs 2024 (€ 208,588) Favourable step	▲ 9%
Land & buildings	-	-	-	€ 268,439 Land & buildings 2025: € 268,439 First fiscal year in the series
Retained profit	€ 112,302 Retained profit 2022: € 112,302 First fiscal year in the series	€ 216,086 Retained profit 2023: € 216,086 ▲ 92% vs 2022 (€ 112,302) Favourable step	€ 378,435 Retained profit 2024: € 378,435 ▲ 75% vs 2023 (€ 216,086) Favourable step	€ 520,772 Retained profit 2025: € 520,772 ▲ 38% vs 2024 (€ 378,435) Favourable step	▲ 38%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 144,651 Bank debt 2025: € 144,651 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 164,575 Balance sheet total 2022: € 164,575 First fiscal year in the series	€ 296,765 Balance sheet total 2023: € 296,765 ▲ 80% vs 2022 (€ 164,575) Unchanged	€ 395,523 Balance sheet total 2024: € 395,523 ▲ 33% vs 2023 (€ 296,765) Unchanged	€ 681,582 Balance sheet total 2025: € 681,582 ▲ 72% vs 2024 (€ 395,523) Unchanged	▲ 72%

Key figures of Dr Leyder, pneumologue, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr Leyder, pneumologue?

What happened at Dr Leyder, pneumologue in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 30, 2026 New annual accounts for financial year 2025: profit of € 142,337 (▼ 12% vs 2024). filed late Source: NBB ↗
Apr 22, 2022 New establishment in Bertrix. KBO
Apr 22, 2022 Start of the company according to the CBE. KBO

In short

From € 112,302 profit in 2022 to € 142,337 profit in 2025.

Paid € 153,972 in corporate taxes since 2022.

Best year ever: 2024, with € 162,348 profit.

Original PDFs at the National Bank ↗

Management

Emmanuel LEYDER

Dr Leyder, pneumologue

Behind Dr Leyder, pneumologue is Emmanuel LEYDER.

Directors

According to the 2025 annual accounts

Emmanuel LEYDER

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Burhaimont 162

6880 Bertrix

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0785.338.130
VAT number: BE 0785.338.130
Registered office: Rue de Burhaimont 162, 6880 Bertrix
Names & denominations: Dr Leyder, pneumologue
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 April 2022
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗